These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3016270)
21. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors. Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116 [TBL] [Abstract][Full Text] [Related]
22. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines. Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991 [TBL] [Abstract][Full Text] [Related]
23. Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue. Williams M; Jarvis MF; Sills MA; Ferkany JW; Braunwalder A Biochem Pharmacol; 1987 Nov; 36(22):4024-7. PubMed ID: 3689436 [No Abstract] [Full Text] [Related]
29. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists. Schneller SW; Ibay AC; Christ WJ; Bruns RF J Med Chem; 1989 Oct; 32(10):2247-54. PubMed ID: 2795597 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine. Pfister JR; Belardinelli L; Lee G; Lum RT; Milner P; Stanley WC; Linden J; Baker SP; Schreiner G J Med Chem; 1997 Jun; 40(12):1773-8. PubMed ID: 9191953 [TBL] [Abstract][Full Text] [Related]
31. Adenosine receptors: development of selective agonists and antagonists. Daly JW; Jacobson KA; Ukena D Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607 [TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors. Katsushima T; Nieves L; Wells JN J Med Chem; 1990 Jul; 33(7):1906-10. PubMed ID: 1694546 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists. Grahner B; Winiwarter S; Lanzner W; Müller CE J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application. Hamilton HW; Ortwine DF; Worth DF; Badger EW; Bristol JA; Bruns RF; Haleen SJ; Steffen RP J Med Chem; 1985 Aug; 28(8):1071-9. PubMed ID: 2991519 [TBL] [Abstract][Full Text] [Related]
35. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors. Jacobson KA; de la Cruz R; Schulick R; Kiriasis L; Padgett W; Pfleiderer W; Kirk KL; Neumeyer JL; Daly JW Biochem Pharmacol; 1988 Oct; 37(19):3653-61. PubMed ID: 3178879 [TBL] [Abstract][Full Text] [Related]
36. Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. Jacobson KA; Kirk KL; Padgett WL; Daly JW J Med Chem; 1985 Sep; 28(9):1334-40. PubMed ID: 2993622 [TBL] [Abstract][Full Text] [Related]
38. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells. Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078 [TBL] [Abstract][Full Text] [Related]
39. A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets. Ukena D; Jacobson KA; Kirk KL; Daly JW FEBS Lett; 1986 Apr; 199(2):269-74. PubMed ID: 3009222 [TBL] [Abstract][Full Text] [Related]
40. Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones. Weyler S; Fülle F; Diekmann M; Schumacher B; Hinz S; Klotz KN; Müller CE ChemMedChem; 2006 Aug; 1(8):891-902. PubMed ID: 16902942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]